Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Alerus Financial Corporation is a banks-regional business based in the US. Alerus Financial Corporation shares (ALRS) are listed on the NASDAQ and all prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
52-week range | USD$14.6225 - USD$30.8 |
---|---|
50-day moving average | USD$27.7406 |
200-day moving average | USD$24.0928 |
Wall St. target price | USD$29 |
PE ratio | 11.5232 |
Dividend yield | USD$0.6 (2.08%) |
Earnings per share (TTM) | USD$2.52 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Alerus Financial Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Alerus Financial Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Alerus Financial Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Alerus Financial Corporation shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Revenue TTM | USD$222.3 million |
---|---|
Operating margin TTM | 28.1% |
Gross profit TTM | USD$222.3 million |
Return on assets TTM | 1.66% |
Return on equity TTM | 14.51% |
Profit margin | 20.1% |
Book value | $19.279 |
Market capitalisation | USD$497.3 million |
TTM: trailing 12 months
There are currently 123,502 Alerus Financial Corporation shares held short by investors – that's known as Alerus Financial Corporation's "short interest". This figure is 5.3% down from 130,351 last month.
There are a few different ways that this level of interest in shorting Alerus Financial Corporation shares can be evaluated.
Alerus Financial Corporation's "short interest ratio" (SIR) is the quantity of Alerus Financial Corporation shares currently shorted divided by the average quantity of Alerus Financial Corporation shares traded daily (recently around 26165.677966102). Alerus Financial Corporation's SIR currently stands at 4.72. In other words for every 100,000 Alerus Financial Corporation shares traded daily on the market, roughly 4720 shares are currently held short.
However Alerus Financial Corporation's short interest can also be evaluated against the total number of Alerus Financial Corporation shares, or, against the total number of tradable Alerus Financial Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Alerus Financial Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Alerus Financial Corporation shares in existence, roughly 10 shares are currently held short) or 0.0084% of the tradable shares (for every 100,000 tradable Alerus Financial Corporation shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Alerus Financial Corporation.
Find out more about how you can short Alerus Financial Corporation stock.
Dividend payout ratio: 23.9% of net profits
Recently Alerus Financial Corporation has paid out, on average, around 23.9% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.11% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Alerus Financial Corporation shareholders could enjoy a 2.11% return on their shares, in the form of dividend payments. In Alerus Financial Corporation's case, that would currently equate to about $0.6 per share.
While Alerus Financial Corporation's payout ratio might seem low, this can signify that Alerus Financial Corporation is investing more in its future growth.
Alerus Financial Corporation's most recent dividend payout was on 8 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 17 December 2020 (the "ex-dividend date").
Alerus Financial Corporation's shares were split on a 3:1 basis on 15 September 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Alerus Financial Corporation shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Alerus Financial Corporation shares which in turn could have impacted Alerus Financial Corporation's share price.
Over the last 12 months, Alerus Financial Corporation's shares have ranged in value from as little as $14.6225 up to $30.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alerus Financial Corporation's is 0.8335. This would suggest that Alerus Financial Corporation's shares are less volatile than average (for this exchange).
Alerus Financial Corporation, through its subsidiary Alerus Financial, National Association, provides various financial services to businesses and consumers in the United States. The company operates through four segments: Banking, Retirement and Benefit Services, Wealth Management, and Mortgage. It offers various deposit products and services, including demand deposits, checking, interest-bearing transaction accounts, money market accounts, time and savings deposits, and certificates of deposit; and treasury management products, including electronic receivables management, remote deposit capture, cash vault services, merchant services, and other cash management services. The company also provides commercial lending products, such as commercial loans, business term loans, lines of credit, and commercial real estate loans, as well as construction and land development loans; consumer lending products, including residential first mortgage loans; and installment loans and lines of credit. In addition, it offers retirement plan administration and investment advisory services, employee stock ownership plan, fiduciary services, payroll, health savings accounts, and other benefit services; and wealth management services, such as financial planning, investment management, personal and corporate trust services, estate administration, and custody services. Further, the company provides debit and credit cards, online banking, mobile banking/wallet, private banking, payroll accounts, flex spending accounts, administration, and government health insurance program services. The company was formerly known as First National Bank North Dakota and changed its name to Alerus Financial Corporation in 2000. Alerus Financial Corporation was founded in 1879 and is headquartered in Grand Forks, North Dakota.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.